GO:0004421 hydroxymethylglutaryl-CoA synthase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004421 describes the enzymatic activity that condenses acetoacetyl-CoA and acetyl-CoA to form (S)-3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), a key step in the mevalonate pathway and ketogenesis.
• The two main human enzymes carrying this activity are HMGCS1 (cytosolic) and HMGCS2 (mitochondrial), which serve distinct metabolic roles in cholesterol synthesis and ketone body production, respectively.
• HMGCS2-mediated ketogenesis protects against diet-induced fatty liver injury and hyperglycemia, and its loss exacerbates hepatosteatosis.
• HMGCS1 is regulated by the mTORC1-CTLH E3 ligase through the Pro/N-degron pathway, linking nutrient sensing to mevalonate pathway control.
• Dysregulation of HMGCS1 contributes to hepatocellular carcinoma progression via YAP1 activation, highlighting its oncogenic potential.
• Studying GO:0004421 requires integrating CRISPR knockout, point mutation, knock-in, overexpression models with metabolomics, proteomics, and activity-based probes.
Description
Hydroxymethylglutaryl-CoA synthase (HMGCS) activity, encoded by GO:0004421, catalyzes the condensation of acetoacetyl-CoA with acetyl-CoA to produce (S)-3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). This reaction is a committed step in the mevalonate pathway, which generates cholesterol and non-sterol isoprenoids, and in the ketogenic pathway, which produces ketone bodies during fasting or low-carbohydrate states. Researchers study this activity to understand metabolic regulation, cellular stress responses, and diseases ranging from metabolic syndrome to cancer. The two human isoforms, HMGCS1 and HMGCS2, are differentially localized and regulated, making them attractive targets for tissue-specific interventions. This article synthesizes current knowledge on the mechanism, key genes, disease relevance, and experimental approaches for investigating GO:0004421.
hydroxymethylglutaryl-CoA synthase activity At A Glance
| GO ID | GO:0004421 |
|---|---|
| GO term | hydroxymethylglutaryl-CoA synthase activity |
| Ontology | molecular_function |
| Synonym | HMG-CoA synthase activity; 3-hydroxy-3-methylglutaryl-CoA synthase activity; acetyl-CoA:acetoacetyl-CoA C-acetyltransferase (thioester-hydrolysing, carboxymethyl-forming) |
| Major function | Condensation of acetoacetyl-CoA and acetyl-CoA to form HMG-CoA |
| Reaction | acetoacetyl-CoA + acetyl-CoA + H2O = (S)-3-hydroxy-3-methylglutaryl-CoA + CoA + H+ |
| Pathways | Mevalonate pathway (cholesterol biosynthesis); ketogenesis |
| Human genes | HMGCS1 (cytosolic), HMGCS2 (mitochondrial) |
What Is GO:0004421?
GO:0004421 hydroxymethylglutaryl-CoA synthase activity is defined as the catalysis of the reaction: acetoacetyl-CoA + acetyl-CoA + H2O = (S)-3-hydroxy-3-methylglutaryl-CoA + CoA + H+. This activity is also known as HMG-CoA synthase activity, 3-hydroxy-3-methylglutaryl-CoA synthase activity, and acetyl-CoA:acetoacetyl-CoA C-acetyltransferase (thioester-hydrolysing, carboxymethyl-forming) [QuickGO]. It belongs to the molecular_function ontology and is essential for both cholesterol biosynthesis and ketogenesis.
Why Is hydroxymethylglutaryl-CoA synthase activity Important in Cell Biology?
GO:0004421 is critical because it governs the flux of acetyl-CoA into two essential metabolic branches: the mevalonate pathway for cholesterol and isoprenoid synthesis, and the ketogenic pathway for energy production during nutrient deprivation. Dysregulation of this activity is linked to fatty liver disease, hyperglycemia, chronic kidney disease, and cancer. Understanding its regulation and function provides insights into metabolic homeostasis and offers therapeutic targets for metabolic and oncological disorders.
• Controls a committed step in cholesterol biosynthesis, affecting membrane integrity and steroid hormone production.
• Essential for ketogenesis, which supplies alternative energy sources during fasting and protects against fatty liver injury.
• Regulated by nutrient-sensing pathways such as mTORC1, linking metabolism to cell growth.
• Implicated in hepatocellular carcinoma progression through YAP1 activation.
• Protects mitochondrial function in chronic kidney disease via HMGCS2.
• Modulated by sirtuin SIRT5 through lysine succinylation.
• Supports intestinal stem cell homeostasis through ketone body signaling.
• Targeted by activity-based probes for chemical proteomics, enabling drug discovery.
• Provides a model for studying enzyme evolution and compartmentalized metabolism.
Molecular Mechanism of hydroxymethylglutaryl-CoA synthase activity
Substrate Binding and Catalysis
In simple terms: The enzyme grabs two molecules, acetoacetyl-CoA and acetyl-CoA, and joins them to make HMG-CoA.
HMGCS catalyzes the Claisen condensation of acetoacetyl-CoA and acetyl-CoA, forming (S)-3-hydroxy-3-methylglutaryl-CoA and releasing CoA and H+. The reaction proceeds through an acetylated enzyme intermediate, where a conserved cysteine residue attacks acetyl-CoA to form a covalent acetyl-enzyme complex, followed by condensation with acetoacetyl-CoA and hydrolysis.
Isoform-Specific Functions
In simple terms: There are two main versions of the enzyme in humans: one in the cytosol for cholesterol, one in mitochondria for ketone bodies.
HMGCS1 is cytosolic and participates in the mevalonate pathway for cholesterol and isoprenoid synthesis, while HMGCS2 is mitochondrial and drives ketogenesis. HMGCS2 is highly expressed in liver and intestine, where it produces ketone bodies during fasting. HMGCS1 is ubiquitously expressed and is regulated by sterol levels and mTORC1 signaling.
Regulation by Nutrient and Energy Status
In simple terms: The enzyme's activity is turned up or down depending on what the cell eats and how much energy it has.
mTORC1 signaling promotes the degradation of HMGCS1 through the CTLH E3 ligase via the Pro/N-degron pathway, linking nutrient availability to mevalonate pathway control. SIRT5 regulates HMGCS2 by removing succinyl groups, affecting its enzymatic activity. Ketone body signaling from HMGCS2 activity influences intestinal stem cell homeostasis and adaptation to diet.
Role in Metabolic Pathways
In simple terms: This enzyme is a gatekeeper that decides whether acetyl-CoA becomes cholesterol or ketone bodies.
The HMG-CoA produced by HMGCS is further reduced to mevalonate by HMG-CoA reductase, the rate-limiting step of cholesterol synthesis. In ketogenesis, HMGCS2-derived HMG-CoA is cleaved to acetoacetate, which is reduced to beta-hydroxybutyrate for export as an energy substrate. This branching point is critical for metabolic flexibility during fasting or high-fat diets.
Key Genes Involved in GO:0004421 hydroxymethylglutaryl-CoA synthase activity
The following genes and proteins are directly involved in or regulate hydroxymethylglutaryl-CoA synthase activity (GO:0004421).
| Gene | Major Role | Research Relevance |
|---|---|---|
| HMGCS1 | Cytosolic HMG-CoA synthase; mevalonate pathway | Regulated by mTORC1-CTLH E3 ligase; target in cancer and metabolic studies |
| HMGCS2 | Mitochondrial HMG-CoA synthase; ketogenesis | Protects against fatty liver and kidney disease; modulated by SIRT5 |
| HMGCR | HMG-CoA reductase; downstream enzyme | Rate-limiting for cholesterol synthesis; target of statins |
| ACAT1 | Acetoacetyl-CoA thiolase; produces acetoacetyl-CoA | Provides substrate for HMGCS in ketogenesis |
| SIRT5 | Desuccinylase; regulates HMGCS2 | Modulates mitochondrial metabolism via succinylation |
| mTORC1 | Nutrient-sensing kinase; promotes HMGCS1 degradation | Links growth signals to mevalonate pathway |
| CTLH E3 ligase | Ubiquitin ligase complex; targets HMGCS1 | Mediates Pro/N-degron-dependent degradation |
| SPOP | E3 ligase substrate adaptor; regulates HMGCS1 | Involved in hepatocellular carcinoma progression |
| CSN6 | COP9 signalosome subunit; regulates SPOP | Modulates HMGCS1 stability in cancer |
| YAP1 | Transcriptional co-activator; downstream of HMGCS1 | Promotes cancer progression when HMGCS1 is dysregulated |
| LONP1 | Mitochondrial protease; targets HMGCS2 | Protects mitochondrial function in kidney disease |
| SCAP | SREBP cleavage-activating protein; sterol sensing | Regulates HMGCS1 transcription via SREBP |
| SREBP-2 | Transcription factor; activates mevalonate genes | Controls HMGCS1 expression in response to sterols |
| PPARalpha | Nuclear receptor; induces HMGCS2 | Drives ketogenesis during fasting |
| FGF21 | Hormone; promotes ketogenesis | Induced by HMGCS2-mediated ketogenesis |
| HNF4alpha | Transcription factor; regulates HMGCS2 | Liver-specific control of ketogenesis |
| CYP7A1 | Cholesterol 7-alpha-hydroxylase; bile acid synthesis | Downstream of mevalonate pathway |
| INSIG | Insulin-induced gene; regulates SREBP | Modulates HMGCS1 transcription |
How Is hydroxymethylglutaryl-CoA synthase activity Regulated?
Hydroxymethylglutaryl-CoA synthase activity is regulated at multiple levels. HMGCS1 is transcriptionally controlled by SREBP-2 in response to sterol levels and is post-translationally degraded by the mTORC1-CTLH E3 ligase via the Pro/N-degron pathway. HMGCS2 is regulated by PPARalpha and HNF4alpha during fasting, and its activity is modulated by SIRT5-mediated desuccinylation. Additionally, ketone body signaling can feedback to influence stem cell homeostasis.
hydroxymethylglutaryl-CoA synthase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HMGCS2 | Fatty liver disease, hyperglycemia | Liver-specific HMGCS2 knockout mice |
| HMGCS1 | Hepatocellular carcinoma | HMGCS1 overexpression in hepatoma cell lines |
| HMGCS2 | Chronic kidney disease | LONP1-HMGCS2 interaction in renal tubular cells |
| HMGCS2 | Intestinal stem cell homeostasis | Intestinal organoids with HMGCS2 knockout |
| HMGCS1 | Mevalonate pathway disorders | CRISPR knockout in cancer cell lines |
Metabolic Liver Disease and Hyperglycemia
HMGCS2-mediated ketogenesis protects against high-fat diet-induced hepatosteatosis and hyperglycemia; loss of HMGCS2 exacerbates fatty liver injury. This positions HMGCS2 as a critical regulator of hepatic lipid metabolism and glucose homeostasis.
Hepatocellular Carcinoma
The CSN6-SPOP-HMGCS1 axis promotes hepatocellular carcinoma progression via YAP1 activation, suggesting that HMGCS1 overexpression or stabilization contributes to tumorigenesis. Targeting this axis may offer therapeutic opportunities.
Chronic Kidney Disease
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease, indicating that HMGCS2 activity is important for renal mitochondrial health.
Intestinal Stem Cell Homeostasis
Ketone body signaling mediated by HMGCS2 regulates intestinal stem cell homeostasis and adaptation to diet, linking this activity to tissue regeneration and metabolic adaptation.
From hydroxymethylglutaryl-CoA synthase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does HMGCS1 loss affect cholesterol synthesis? | HMGCS1 knockout cell lines (e.g., HepG2) |
| Does HMGCS2 point mutation alter ketogenesis? | HMGCS2 point-mutation knock-in mice |
| Can HMGCS1 be tagged for localization studies? | Knock-in of fluorescent tag at HMGCS1 locus |
| Does HMGCS1 overexpression promote cancer? | HMGCS1 overexpression in hepatocellular carcinoma cells |
| How does SIRT5 regulate HMGCS2? | SIRT5 knockout or point-mutation models |
| What is the role of HMGCS2 in stem cells? | Intestinal organoids with inducible HMGCS2 knockout |
How to Study the hydroxymethylglutaryl-CoA synthase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Metabolomics | Levels of HMG-CoA, mevalonate, ketone bodies | Assessing pathway flux |
| Activity-based probes | Active HMGCS1 enzyme | Chemical proteomics and inhibitor screening |
| Succinylome profiling | Lysine succinylation of HMGCS2 | SIRT5 regulation studies |
| CRISPR knockout screens | Gene essentiality and synthetic lethality | Cancer dependency mapping |
| RNA-seq | Transcriptional changes in mevalonate/ketogenic genes | SREBP/PPARalpha target analysis |
| Western blot | Protein levels of HMGCS1/2 | Degradation and stability assays |
| Immunofluorescence | Subcellular localization | Mitochondrial vs cytosolic distribution |
| 13C tracing | Metabolic flux | Ketogenesis and cholesterol synthesis |
Metabolomics and Flux Analysis
Metabolomics can quantify HMG-CoA, mevalonate, and ketone bodies to assess HMGCS activity in cells and tissues. Stable isotope tracing with 13C-acetyl-CoA can measure flux through the mevalonate and ketogenic pathways.
Proteomics and Activity-Based Probes
Activity-based probes and chemical proteomics enable direct profiling of HMGCS1 activity and its inhibition in complex proteomes. Succinylome analysis by mass spectrometry reveals SIRT5-mediated regulation of HMGCS2.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify synthetic lethal interactions with HMGCS1 or HMGCS2, revealing pathway dependencies in cancer and metabolic diseases.
Imaging and Subcellular Localization
Fluorescent tagging of HMGCS1 or HMGCS2 via knock-in allows live-cell imaging of their subcellular localization and dynamics.
How CRISPR Can Be Used to Study GO:0004421 hydroxymethylglutaryl-CoA synthase activity
Knockout
CRISPR knockout of HMGCS1 or HMGCS2 enables loss-of-function studies to determine their roles in cholesterol synthesis, ketogenesis, and disease models. For example, HMGCS2 knockout mice develop fatty liver under high-fat diet.
Point Mutation
Introducing point mutations in catalytic residues (e.g., active-site cysteine) of HMGCS1/2 via CRISPR can dissect enzymatic activity from non-enzymatic functions. Such models help validate specific catalytic mechanisms.
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) at endogenous HMGCS1 or HMGCS2 loci allows for precise localization, interaction, and degradation studies without overexpression artifacts.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of HMGCS1/2 can model gain-of-function phenotypes, such as cancer progression or enhanced ketogenesis.
How EDITGENE Supports hydroxymethylglutaryl-CoA synthase activity Research
Researchers studying hydroxymethylglutaryl-CoA synthase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for hydroxymethylglutaryl-CoA synthase activity research.
Frequently Asked Questions About hydroxymethylglutaryl-CoA synthase activity
What is hydroxymethylglutaryl-CoA synthase activity?
It is the enzymatic activity (GO:0004421) that catalyzes the condensation of acetoacetyl-CoA and acetyl-CoA to form HMG-CoA, a key step in cholesterol synthesis and ketogenesis.
What genes are involved in hydroxymethylglutaryl-CoA synthase activity?
The main human genes are HMGCS1 (cytosolic) and HMGCS2 (mitochondrial), which encode the two isoforms of the enzyme.
What is the difference between HMGCS1 and HMGCS2?
HMGCS1 is cytosolic and functions in the mevalonate pathway for cholesterol synthesis, while HMGCS2 is mitochondrial and drives ketogenesis.
How is HMGCS1 regulated?
HMGCS1 is transcriptionally regulated by SREBP-2 and post-translationally degraded by the mTORC1-CTLH E3 ligase via the Pro/N-degron pathway.
What diseases are associated with HMGCS2?
HMGCS2 is linked to fatty liver disease, hyperglycemia, chronic kidney disease, and intestinal stem cell homeostasis.
Can CRISPR be used to study HMGCS activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect HMGCS function in cells and animals.
What methods measure HMGCS activity?
Metabolomics, activity-based probes, and stable isotope tracing are commonly used to measure HMGCS activity and pathway flux.
Is HMGCS1 a cancer target?
HMGCS1 promotes hepatocellular carcinoma progression via YAP1 activation, making it a potential therapeutic target.
How does SIRT5 affect HMGCS2?
SIRT5 desuccinylates HMGCS2, modulating its enzymatic activity and mitochondrial metabolism.
What model organisms are used to study HMGCS2?
Mouse models with liver-specific or inducible HMGCS2 knockout are commonly used to study ketogenesis and metabolic disease.
Conclusion
Hydroxymethylglutaryl-CoA synthase activity (GO:0004421) is a fundamental enzymatic activity at the crossroads of cholesterol synthesis and ketogenesis. Its two human isoforms, HMGCS1 and HMGCS2, are differentially regulated and implicated in a range of diseases from fatty liver to cancer. Continued research using advanced CRISPR models and multi-omics approaches will further illuminate its therapeutic potential. EDITGENE offers a full suite of services to support these investigations.
References
- 1. Asif S et al.. 2022. Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis.. Mol Metab 61:101494 PMID: 35421611
- 2. Yi SA et al.. 2024. mTORC1-CTLH E3 ligase regulates the degradation of HMG-CoA synthase 1 through the Pro/N-degron pathway.. Mol Cell 84(11):2166-2184.e9 PMID: 38788716
- 3. Li K et al.. 2024. CSN6-SPOP-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation.. Adv Sci (Weinh) 11(14):e2306827 PMID: 38308184
- 4. Bai M et al.. 2023. LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease.. EMBO Mol Med 15(2):e16581 PMID: 36629048
- 5. Rardin MJ et al.. 2013. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks.. Cell Metab 18(6):920-33 PMID: 24315375
- 6. Cheng CW et al.. 2019. Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet.. Cell 178(5):1115-1131.e15 PMID: 31442404
- 7. Yi SA et al.. 2025. Activity-based probes and chemical proteomics uncover the biological impact of targeting HMG-CoA Synthase 1 in the mevalonate pathway.. J Biol Chem 301(10):110660 PMID: 40912656
- 8. Cotter DG et al.. 2014. Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia.. J Clin Invest 124(12):5175-90 PMID: 25347470
